Article Text

other Versions


Heterozygous disruption of SERCA2a is not associated with impairment of cardiac performance in man: implications for SERCA2a as a therapeutic target in heart failure

Statistics from

This is a PDF-only article. The first page of the PDF of this article appears below.

PDF extract preview

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.